Clinical Trial Update: Interest of S100B Protein for Patient Victim of Minor Traumatic Brain Injury and Treated by Antiplatelet [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the role of the S100B protein in patients with mild traumatic brain injury who are treated with antiplatelet therapy has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Snippet

Sponsor: Poitiers University Hospital | Conditions: Minor Traumatic Brain Injury, Treatment by Antiplatelet | Phase 3 | Status: COMPLETED